November 04, 2026

Proscia: Choosing the Right Digital Pathology Platform: 7 Criteria for a Better Experience with Your AI Applications

From the Proscia blog: Labs now expect their digital pathology platform to offer a broad range of AI applications from multiple vendors. But access alone isn’t enough. The platform also shapes how pathologists, scientists, and lab teams experience these...

recent articles

ArteraAI, CorePlus collaboration aims to further validate the ArteraAI Prostate Test in the Hispanic population SAN FRANCISCO--(BUSINESS WIRE)--ArteraAI, the developer of multimodal artificial intelligence (MMAI) based predictive and...

Indica Labs has announced a webinar for February 2024 teaching attendees about applications of the ACD RNAscope™ HiPlex assay. Hedgehog Signaling pathway in Thymic Differentiation - An in situ Single Cell Resolution Investigation Date:...

Montville, NJ – December 11, 2023 – PathPresenter, the global image-sharing platform for pathology, was recently selected by Cincinnati Children’s to provide an integrated digital pathology workflow solution to meet the health system’s...

Proscia: Distributing real-world data to researchers in hours instead of days SAN FRANCISCO and PHILADELPHIA – December 12, 2023 – The AIDS and Cancer Specimen Resource (ACSR), a biorepository of specimens collected from persons living...

Gestalt: Algorithm designed to save time for pathologists Gestalt Diagnostics LLC has launched an artificial intelligence-assisted algorithm that can be used to aid pathologists in grading and classifying eight types of cancers through...

Lumea: Enabling pathologists to use cutting-edge diagnostic solutions for decision support in Gleason grading prostate cancer specimens. LEHI, UTAH, USA, December 7, 2023 /EINPresswire.com/ -- Lumea Inc., a leader in integrated digital...

OR

platinum partners

gold partners

Silver Partners

Media Partners